Valuation: Procyon Corporation

Market Cap 1.55M 1.36M 1.25M 1.16M 2.19M 148M 2.24M 15.06M 5.85M 72.48M 5.81M 5.68M 252M P/E 2023
-25x
P/E 2024 -5.75x
Enterprise Value 1.06M 934K 862K 797K 1.51M 102M 1.54M 10.36M 4.03M 49.89M 4M 3.91M 173M EV / Sales 2023
0.34x
EV / Sales 2024 0.28x
Free-Float
35.53%
Yield 2023 *
-
Yield 2024 -
3 months-28.21%
6 months+66.12%
Current year+66.12%
Current year 0.12
Extreme 0.12
0.28
1 year 0.1
Extreme 0.1
0.28
3 years 0
Extreme 0
0.34
5 years 0
Extreme 0
0.64
10 years 0
Extreme 0
1
Manager TitleAgeSince
Chief Executive Officer 49 09/01/2018
Chief Executive Officer 56 22/09/2005
Director TitleAgeSince
Director/Board Member 49 01/01/2006
Director/Board Member 56 01/12/2006
Chairman 79 01/09/2005
Date Insider Type Main position Quantity % Market Cap.
31/07/24Other

Director

7,200 0.0888%
31/07/24Other

Director

5,600 0.0691%
31/07/24Other

Director

12,848 0.1585%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%+5.79%-18.95% 1.65M
-0.01%+0.20%+54.56%+168.40% 1,084B
-0.95%-0.60%+67.30%+63.91% 634B
-0.17%-3.52%+32.14%+87.29% 447B
+0.01%-1.93%+28.81%+26.26% 330B
-7.43%-9.67%+26.73%+29.00% 295B
-1.20%-2.73%+27.65%+45.16% 285B
-0.70%-3.39%-27.60%-39.58% 218B
-1.13%-2.89%+22.54%+61.68% 199B
-1.10%+2.48%+18.79%+77.72% 169B
Average -1.27%+2.27%+25.67%+50.09% 365.99B
Weighted average by Cap. -1.04%+2.48%+39.09%+84.40%

Financials

2023 2024
Net sales 4.69M 4.11M 3.8M 3.51M 6.65M 449M 6.78M 45.62M 17.73M 220M 17.6M 17.21M 762M 4.98M 4.37M 4.04M 3.73M 7.07M 477M 7.21M 48.52M 18.85M 234M 18.72M 18.31M 811M
Net income -50.24K -44.07K -40.69K -37.6K -71.26K -4.81M -72.69K -489K -190K -2.35M -189K -185K -8.17M -341K -299K -276K -255K -484K -32.66M -494K -3.32M -1.29M -15.98M -1.28M -1.25M -55.49M
Net Debt -427K -375K -346K -320K -606K -40.93M -618K -4.16M -1.62M -20.03M -1.61M -1.57M -69.53M -482K -423K -390K -361K -684K -46.16M -697K -4.69M -1.82M -22.59M -1.81M -1.77M -78.42M
Logo Procyon Corporation
Procyon Corporation operates through its subsidiary AMERX Health Care Corporation (AMERX). AMERX develops and markets medical products used in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation and other skin problems. It provides skin and wound care products through its proprietary brands, AMERIGEL Advanced Skin and Wound Care, HELIX3 Bioactive Collagen, and EXTREMIT-EASE compresson Garment. Its AMERIGEL products are made with Oakin, that promote healing in wounds and problematic skin conditions while fighting infection, including AMERIGEL Hydrogel Wound Dressing, AMERIGEL Post Op Surgical Kits, AMERIGEL Saline Wound Wash, AMERIGEL Care Lotion, and AMERIGEL Barrier Lotion. HELIX3 is available in Collagen Powder (HELIX3 CP) and Collagen Matrix (HELIX3 CM). Its kits and dressings products include AMERX Calcium Alginate Dressing, AMERX Foam Dressing, AMERX Gauze Dressing, AMERX Thin Hydrocolloid Dressings, and AMERX Wound Care Kits.
Employees
20
  1. Stock Market
  2. Stocks
  3. PCYN Stock